Summary
CAH Chart
Cardinal Health raises annual profit target
Drug distributor Cardinal Health raised its annual adjusted profit forecast on Thursday, banking on demand for costly specialty medicines and branded drugs at its pharmaceuticals unit.
Cardinal Health Details Momentum and Updated Long-Term Value Creation Plans at Investor Day
Key announcements: Raising FY25 non-GAAP diluted EPS guidance to $8.15 to $8.20 1 Establishing preliminary FY26 non-GAAP diluted EPS guidance of $9.10 to $9.30 (13% growth at the mid-points)2 Confirming long-term target of 12% to 14% non-GAAP diluted EPS CAGR for FY26 to FY283 Raising long-term target for Pharmaceutical and Specialty Solutions profit to 5% to 7% normalized growth3,4 Raising long-term target for Other profit to ~10% normalized growth3,4,5 Updating GMPD long-term target to $50M+ of profit growth per year after FY26 Expecting at least $10B in total adjusted free cash flow over next three years Raising baseline share repurchase plans to at least $750M per year Company reiterating strategic priorities and providing updates across its businesses DUBLIN, Ohio , June 12, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today will host an Investor Day beginning at 9:00 a.m. ET, where management will detail its growth strategies to maximize the company's potential for all stakeholders.
Cardinal Health launches new medical device for the continuous monitoring of three essential vital signs in one system
Kendall DLâ„¢ Multi System simplifies patient monitoring, drives efficiencies for providers DUBLIN, Ohio , June 4, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today the U.S. launch of its multi-parameter, single-patient use monitoring cable and lead wire system that enables the continuous monitoring of cardiac activity, blood oxygen level and temperature with one point of connection. The new Kendall DLâ„¢ Multi System is designed to travel with the patient from admission to discharge for smooth transport.
Cardinal Health Inc. Dividends
 CAH In 2 weeks Announced | Quarterly | $0.51 Per Share |
| CAH 2 months ago Paid | Quarterly | $0.51 Per Share |
| CAH 5 months ago Paid | Quarterly | $0.51 Per Share |
| CAH 8 months ago Paid | Quarterly | $0.51 Per Share |
| CAH 11 months ago Paid | Quarterly | $0.51 Per Share |
Cardinal Health Inc. Earnings
| 30 Apr 2025 Date | | - Cons. EPS | - EPS |
| 30 Jan 2025 Date | | 1.76 Cons. EPS | 1.93 EPS |
| 1 Nov 2024 Date | | 1.62 Cons. EPS | 1.88 EPS |
| 14 Aug 2024 Date | | 1.73 Cons. EPS | 1.84 EPS |
| 13 Aug 2024 Date | | 1.73 Cons. EPS | - EPS |
| CAH In 2 weeks Announced | Quarterly | $0.51 Per Share |
| CAH 2 months ago Paid | Quarterly | $0.51 Per Share |
| CAH 5 months ago Paid | Quarterly | $0.51 Per Share |
| CAH 8 months ago Paid | Quarterly | $0.51 Per Share |
| CAH 11 months ago Paid | Quarterly | $0.51 Per Share |
| 30 Apr 2025 Date | | - Cons. EPS | - EPS |
| 30 Jan 2025 Date | | 1.76 Cons. EPS | 1.93 EPS |
| 1 Nov 2024 Date | | 1.62 Cons. EPS | 1.88 EPS |
| 14 Aug 2024 Date | | 1.73 Cons. EPS | 1.84 EPS |
| 13 Aug 2024 Date | | 1.73 Cons. EPS | - EPS |
Cardinal Health Inc. (CAH) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Cardinal Health Inc. ever had a stock split?
Cardinal Health Inc. Profile
| Medical - Distribution Industry | Healthcare Sector | Mr. Jason M. Hollar CEO | NYSE Exchange | 14149Y108 Cusip |
| US Country | 47,922 Employees | 1 Apr 2025 Last Dividend | 23 Apr 2001 Last Split | 31 Dec 1987 IPO Date |
Overview
Cardinal Health, Inc. is a prominent provider of healthcare services and products with a global presence, including operations in the United States, Canada, Europe, Asia, and other international territories. The company caters to a wide range of healthcare needs by offering customized solutions specifically designed for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and also for patients at home. With its foundation laid in 1979 and having its headquarters in Dublin, Ohio, Cardinal Health is organized into two main segments: Pharmaceutical and Medical, through which it facilitates an extensive array of health care products and services.
Products and Services
The company's operations are broadly categorized into two segments, each offering a variety of products and services.
- Pharmaceutical Segment:
This segment involves the distribution of branded and generic pharmaceuticals, specialty pharmaceutical and over-the-counter healthcare and consumer products. It extends its services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products. The operations include running nuclear pharmacies, radiopharmaceutical manufacturing facilities, repackaging generic pharmaceuticals and over-the-counter healthcare products, and providing pharmacy management services to hospitals. This broad range ensures a steady supply of essential drugs and healthcare products to various healthcare providers.
- Medical Segment:
Under this segment, Cardinal Health manufactures, sources, and distributes an array of branded medical, surgical, and laboratory products. The list includes:
- Exam and surgical gloves, highlighting the company's dedication to safety and hygiene in healthcare settings.
- Needles, syringe, and sharps disposals, which are essential for infection control.
- Compressions and incontinence products, catering to a wide range of patient needs.
- Nutritional delivery products and wound care products that support patient recovery and care.
- Single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; and operating room supply products, which are crucial for surgical operations and procedures.
- Electrode product lines, further demonstrating the company's wide range in healthcare solutions.
Contact Information
